CNL’S Vision to Become a World Leader in Actinium-225 is Coming to Life
Canadian Nuclear Laboratories (CNL),
Canada’s premier nuclear science and technology laboratory, is celebrating a
key milestone in its vision to become a world leader in the research and
production of Actinium-225, a promising but very rare medical isotope. The end
of 2022 marked five years since the first successful shipment of Actinium-225.
To read more please visit:
CNL’S
Vision to Become a World Leader in Actinium-225 is Coming to Life
Source: CNL